Delivery Order SPE2DB25D3201-SPE2DB25FNTPJ
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Truqap 200 mg tablets (64-count) with a ceiling value of $31,028.80. This is a firm fixed-price delivery order with an ultimate completion date of May 13, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- On August 4, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,028.80 to AmerisourceBergen Drug Corp for Truqap 200 mg tablets (64-count). This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for completion by August 25, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on June 17, 2025, for Truqap 200 mg tablets (64-count packaging). This firm fixed-price delivery order, valued at $15,514.40, is not designated as a set-aside contract and is scheduled for completion by July 10, 2025. The delivery will be performed at AmerisourceBergen's Conshohocken facility. This delivery order is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Truqap 200 mg tablets (64 count) valued at $93,086.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a standard...
- The Defense Logistics Agency awarded a $31,028.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for 64 tablets of Truqap 200 mg, a pharmaceutical product, with an ultimate completion date of September 4, 2025. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $13,545.48 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Truqap 200 mg tablets (64-count packaging). This firm fixed-price delivery order carries a ceiling value of $62,057.60 and is scheduled for completion by September 17, 2025. The contract was competitively awarded without set-aside designations and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $140,578.74 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $45,177.29 by the Defense Logistics Agency's Medical Supply Chain on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNTPJDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 2, 2025, for Truqap 200 mg tablets (64-count units) with a ceiling value of $15,514.40. The contract, which is not set-aside and competitively awarded, carries a firm fixed price structure and an ultimate completion date of June 24, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Defense Logistics Agency procures this pharmaceutical product to support the medical supply chain for military and veteran healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a preferred vendor for federal medical procurement, with delivery orders consistently involving brand-name and generic medications across multiple therapeutic domains. The company's IDC with DLA serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, and the agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key participant in this strategic initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 6/2/25 |